Can a temporary heart pump save more lives in cardiogenic shock?

NCT ID NCT07762560

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial investigates whether using a temporary heart pump (microaxial flow pump) right after opening a blocked artery improves survival in people with cardiogenic shock—a life-threatening condition where the heart can't pump enough blood. It also tests whether advanced monitoring with a pulmonary artery catheter, which guides precise medication adjustments, helps more than standard ICU monitoring. Adults with heart attack-related shock are randomly assigned to one of four combinations of these treatments. The main goal is to see if these strategies reduce the risk of death within 180 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Microaxial flow pump (a temporary heart pump) and pulmonary artery catheter (a monitoring device)
What this could lead to
If effective, this could establish a new standard of care for cardiogenic shock after a heart attack, potentially improving survival rates.
What could go wrong
The trial is large but early-stage, and the devices carry risks like bleeding, infection, or vascular damage. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Heart Center Leipzig at University of Leipzig

    Leipzig, Saxony, 04289, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.